-
1 Comment
PT Kalbe Farma Tbk is currently in a long term uptrend where the price is trading 104.9% above its 200 day moving average.
From a valuation standpoint, the stock is 74.0% cheaper than other stocks from the Other sector with a price to sales ratio of 3.3.
PT Kalbe Farma Tbk's total revenue rose by 3.6% to $6T since the same quarter in the previous year.
Its net income has increased by 19.4% to $706B since the same quarter in the previous year.
Based on the above factors, PT Kalbe Farma Tbk gets an overall score of 4/5.
| Exchange | F |
|---|---|
| CurrencyCode | EUR |
| ISIN | ID1000125107 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Market Cap | 3B |
|---|---|
| Dividend Yield | 3.1% |
| Beta | 0.16 |
| PE Ratio | 0.0 |
| Target Price | None |
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for LCLA.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
